Norges Bank Karuna Therapeutics, Inc. Transaction History

Norges Bank

  • $716 Trillion
  • Q3 2024

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024
BUY
$161.01 - $317.85 $52.8 Million - $104 Million
328,067 New
328,067 $104 Million
Q3 2023

Nov 13, 2024
BUY
$164.66 - $218.08 $54.3 Million - $72 Million
330,069 New
330,069 $55.8 Million
Q3 2023

Nov 13, 2023
SELL
$164.66 - $218.08 $43 Million - $56.9 Million
-261,109 Closed
0 $0
Q2 2023

Aug 14, 2024
BUY
$176.32 - $240.22 $48.8 Million - $66.5 Million
276,711 New
276,711 $60 Million
Q2 2023

Aug 14, 2023
SELL
$176.32 - $240.22 $34.9 Million - $47.5 Million
-197,673 Closed
0 $0
Q1 2023

May 15, 2024
BUY
$161.33 - $204.36 $55.8 Million - $70.7 Million
345,944 New
345,944 $62.8 Million
Q4 2022

Feb 14, 2023
BUY
$191.53 - $236.82 $59.7 Million - $73.8 Million
311,485 New
311,485 $61.2 Million
Q3 2022

Nov 13, 2023
BUY
$123.79 - $277.42 $32.3 Million - $72.4 Million
261,109 New
261,109 $58.7 Million
Q2 2022

Aug 14, 2023
BUY
$93.97 - $143.33 $18.6 Million - $28.3 Million
197,673 New
197,673 $25 Million
Q1 2022

May 12, 2023
SELL
$98.9 - $132.37 $11.2 Million - $14.9 Million
-112,823 Reduced 36.22%
198,662 $25.2 Million
Q1 2022

May 09, 2022
SELL
$98.9 - $132.37 $21.1 Million - $28.2 Million
-212,862 Closed
0 $0
Q4 2021

Mar 09, 2022
BUY
$110.64 - $159.4 $23.6 Million - $33.9 Million
212,862 New
212,862 $27.9 Million
Q3 2021

Nov 14, 2022
BUY
$101.2 - $125.87 $18.6 Million - $23.1 Million
183,640 New
183,640 $22.5 Million
Q3 2021

Nov 05, 2021
SELL
$101.2 - $125.87 $16.3 Million - $20.3 Million
-160,909 Closed
0 $0
Q2 2021

Aug 15, 2022
BUY
$107.45 - $135.95 $17.3 Million - $21.9 Million
160,909 New
160,909 $18.3 Million
Q2 2021

Aug 10, 2021
SELL
$107.45 - $135.95 $8 Million - $10.1 Million
-74,414 Closed
0 $0
Q1 2021

May 09, 2022
BUY
$95.46 - $133.08 $7.1 Million - $9.9 Million
74,414 New
74,414 $8.95 Million
Q1 2021

May 07, 2021
SELL
$95.46 - $133.08 $17.1 Million - $23.9 Million
-179,307 Closed
0 $0
Q4 2020

Mar 02, 2021
BUY
$75.23 - $109.23 $13.5 Million - $19.6 Million
179,307 New
179,307 $18.2 Million
Q4 2020

Feb 10, 2021
SELL
$75.23 - $109.23 $13.2 Million - $19.2 Million
-176,094 Closed
0 $0
Q3 2020

Nov 12, 2021
BUY
$71.31 - $109.74 $12.6 Million - $19.3 Million
176,094 New
176,094 $13.6 Million
Q3 2019

Nov 08, 2019
SELL
$16.05 - $27.35 $160,500 - $273,500
-10,000 Closed
0 $0
Q2 2019

Aug 13, 2020
BUY
$20.02 - $20.02 $200,200 - $200,200
10,000 New
10,000 $200,000

Others Institutions Holding KRTX

# of Institutions
10
Shares Held
332K
Call Options Held
0
Put Options Held
0
View Full List

About Karuna Therapeutics, Inc.

KRTX Quotes by TradingView
  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email